Fig. 4

Decreased EpCAM by doxorubicin slowed done the tumor growth in vivo. a EpCAM expression was decreased in Hep3B cells after doxorubicin treatment at 0.5 μM for 24 h. b Doxorubicin pretreatment significantly deceased tumor size in vivo compared to untreated group. Data are presented as mean ± SD. *p <0.05 vs untreated Hep3B inoculation group